INTRODUCTION
Leiomyosarcomas are rare malignant smooth muscle tumors that most commonly arise from the uterus, gastrointestinal tract, retroperitoneum or soft tissue. They comprise less than 1% of all cancers and 2% to 9% of sarcomas [1] . These tumors usually grow and metastasize slowly, most commonly to the lung. Primary pulmonary leiomyosarcomas are extremely rare, accounting for less than 0.5% of all malignant lung tumors [2] . We report the case of a female patient with a history of lobectomy for pulmonary leiomyosarcoma, who presented with metastasis to the intrapancreatic common bile duct (CBD) and survived 5.5 years after the first diagnosis.
CASE REPORT
A 57-year-old female patient was referred to our department for surgical treatment of an intrapancreatic CBD tumor. The patient's past medical history was significant for hysterectomy and unilateral oophorectomy due to uterine leiomyoma ten years prior., and primary pulmonary leiomyosarcoma, which was treated with right upper lobectomy and lymph node dissection six months prior to her presentation. In order to diagnose the primary origin of the tumor, the patient underwent abdominal magnetic resonance imaging (MRI), which was negative. Histopathologic examination of the specimen revealed a malignant mesenchymal neoplasm, measuring 6 cm in greatest dimension, with morphological characteristics and immunophenotype compatible with leiomyosarcoma. Cell Soon after the second surgery, the patient was set on adjuvant chemotherapy with gemcitabine plus docetaxel for the pulmonary metastases. Effective eradication of lung lesions was never accomplished and fifty eight months after the first surgery, the patient developed bone metastases. Ten months later the patient died, five and a half years after the first diagnosis of leiomyosarcoma.
DISCUSSION
Leiomyosarcomas are rare, comprising less than 1% of all cancers. Moreover, primary leiomyosarcomas of the lung are extremely rare. These tumors tend to metastasize hematogenously, late in the disease process, most commonly to the lung [3] .
When seen in the lung, it is important to establish whether a leiomyosarcoma originated in the lung or if it is secondary to metastases from a separate location, the latter being much more common. Yet, in our patient the negative abdominal MRI scan before the first surgery suggests that the CBD tumor was probably metastatic. Similarly, the bilateral pulmonary lesions detected in the chest CT scan represented intrapulmonary metastases, as they were not present before the first surgery. Despite the existence of metastatic pulmonary disease and the undetermined histological type of the tumor, the Whipple procedure was decided upon given the patient's good physical status and the fact that the CBD tumor had caused recurrent episodes of cholangitis.
Low-grade lesions and all lesions smaller than 5 cm are generally considered "cured" if adequately resected [4] .
By contrast, the median survival for patients with unresectable sarcoma or metastatic disease is about 12 months [5] . Yet, large tumor size is not a precise predictor of adverse outcome. In leiomyomatous tumors, mitotic figures have been suggested to be the most important predicting parameter [6] . In our case the primary lung tumor was poorly differentiated, measuring 6 cm in diameter. [7] . In conclusion, we could exclude that both the lung tumor and the CBD tumor represented metastases from a STUMP, recurring as leiomyosarcoma.
To our knowledge, this represents the first reported case demonstrating metastasis from primary pulmonary leiomyosarcoma to the intrapancreatic CBD, resulting in a remarkably long survival. The authors believe that, in similar cases, surgeons should be encouraged to treat metastases surgically, even if this requires major resections.
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